Intellectual property and the valuation of biotechnology

Elli Malki ()

Finance from EconWPA

Abstract: The role of intellectual property (IP) as an important value determinant is widely recognized. This article tries to quantify the role of IP in companies valuation by comparing a sample of biotechnology companies (46 companies included in the Genetic Engineering News Index:GEN-Dex) to the companies included in the Dow Jones Index. Conventional wisdom suggests that the biotechnology sector derives more significant portion of its value from IP. The article proposes a new measure for the significance of IP in the determination of value, which is named the IP Intensity (IPI). Comparison of the distribution of IPI in the two samples demonstrates that this measure is a useful tool for the analysis of value determination.

Keywords: valuation; intellectual; property; biotechnology; value (search for similar items in EconPapers)
JEL-codes: G10 G12 K11 L65 M21 M40 O34 (search for similar items in EconPapers)
Date: 1997-09-25
Note: Type of Document - Word; prepared on IBM PC ; to print on HP;
View citations in EconPapers

Downloads: (external link)
http://129.3.20.41/eps/fin/papers/9709/9709002.html (text/html)
http://129.3.20.41/eps/fin/papers/9709/9709002.pdf (application/pdf)
http://129.3.20.41/eps/fin/papers/9709/9709002.ps.gz (application/postscript)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:wpa:wuwpfi:9709002

Access Statistics for this paper

More papers in Finance from EconWPA
Series data maintained by EconWPA ().